INNOCAN PHARMA Corp SEC filings INNPF
INNOCAN PHARMA Corp has 48 filings in SEC EDGAR's recent list, going back to Oct 26, 2021. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| FWP | Free writing prospectus | Apr 3, 2026 | — |
| F-1/A | Filing | Apr 3, 2026 | — |
| FWP | Free writing prospectus | Mar 16, 2026 | — |
| F-1 | Registration statement (foreign issuer) | Mar 16, 2026 | — |
| RW | Filing | Feb 23, 2026 | — |
| EFFECT | Filing | Jan 30, 2026 | — |
| CORRESP | Letter to the SEC | Jan 27, 2026 | — |
| CORRESP | Letter to the SEC | Jan 27, 2026 | — |
| F-1/A | Filing | Jan 7, 2026 | — |
| FWP | Free writing prospectus | Jan 6, 2026 | — |
| F-1/A | Filing | Jan 6, 2026 | — |
| 8-A12B/A | Filing | Dec 22, 2025 | — |
| 8-A12B/A | Filing | Dec 19, 2025 | — |
| 8-A12B/A | Filing | Dec 16, 2025 | — |
| FWP | Free writing prospectus | Dec 10, 2025 | — |
| F-1/A | Filing | Dec 10, 2025 | — |
| DEL AM | Filing | Nov 10, 2025 | — |
| F-1/A | Filing | Oct 22, 2025 | — |
| FWP | Free writing prospectus | Oct 1, 2025 | — |
| F-1/A | Filing | Sep 30, 2025 | — |
| CORRESP | Letter to the SEC | Sep 24, 2025 | — |
| 8-A12B | Filing | Sep 22, 2025 | — |
| CORRESP | Letter to the SEC | Sep 22, 2025 | — |
| CORRESP | Letter to the SEC | Sep 22, 2025 | — |
| FWP | Free writing prospectus | Sep 12, 2025 | — |
| FWP | Free writing prospectus | Sep 5, 2025 | — |
| F-1/A | Filing | Sep 5, 2025 | — |
| CORRESP | Letter to the SEC | Aug 4, 2025 | — |
| F-1/A | Filing | Aug 4, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 29, 2025 | — |
| CORRESP | Letter to the SEC | Jul 23, 2025 | — |
| F-1 | Registration statement (foreign issuer) | Jul 23, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 27, 2025 | — |
| DRS/A | Filing | Jun 20, 2025 | — |
| DRSLTR | Filing | May 15, 2025 | — |
| DRS/A | Filing | May 15, 2025 | — |
| UPLOAD | Letter from the SEC | May 14, 2025 | — |
| DRSLTR | Filing | May 12, 2025 | — |
| DRS/A | Filing | May 12, 2025 | — |
| UPLOAD | Letter from the SEC | May 8, 2025 | — |
| DRSLTR | Filing | May 1, 2025 | — |
| DRS/A | Filing | May 1, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 11, 2025 | — |
| DRSLTR | Filing | Mar 28, 2025 | — |
| DRS/A | Filing | Mar 28, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 28, 2025 | — |
| DRS | Filing | Dec 31, 2024 | — |
| D | Filing | Oct 26, 2021 | — |
Showing 48 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INNPF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Calgary
- SEC CIK
- 1889791
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.